Association between injection practices and duration of injection among recently initiated injection drug users

Drug and Alcohol Dependence

Volumn 75, Issue 2, 2004, Pages 177-183

  Becker Buxton, Meredith ^a,h   Vlahov, David ^a   Strathdee, Steffanie A ^b   Des Jarlais, Don C ^c   Morse, Edward V ^d   Ouellet, Lawrence ^e   Kerndt, Peter ^f   Garfein, Richard S ^g  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d TULANE UNIVERSITY   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f Los Angeles County Department of Public Health   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidemiology; HIV; Injection drug users; Risk factors

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; URBAN AREA;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COMMUNICABLE DISEASES; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 3242758232     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2004.01.014     Document Type: Article

References (25)

1. Chaisson R., Moss A., Onishi R., Osmond D., Carlson J. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am. J. Pub. Health. 77:1987;169-172
2. Diaz T., Des Jarlais D., Vlahov D., Perlis T., Edwards V., Friedman S., Rockwell R., Hoover D., Williams I., Monterroso E. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am. J. Pub. Health. 91:2001;23-30
3. Doherty M., Garfein R., Monterroso E., Brown D., Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 14:2000;717-726
4. Garfein R., Doherty M., Monterroso E., Thomas D., Nelson K., Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Syndr. 18:1998;S11-S19
5. Garfein R., Vlahov D., Galai N., Doherty M., Nelson K. Viral infection in short-term injection drug users: the prevalence of hepatitis C, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Pub. Health. 86:1996;655-661
6. Garten R., Lai S., Zhang J., Liu W., Chen J., Vlahov D., Yu X. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int. J. Epidemiol. 33:2003;1-7
7. Heckathorn, D., Broadhead, R., 1996. In: Eleventh International Conference on AIDS. Vancouver, Canada.
8. Kral A., Blumenthal R., Lorvick J., Gee L., Bacchetti P., Edlin B. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 357:2001;1397-1401
9. Levine O., Vlahov D., Galai N., Brookmeyer R., Cohn S., Nelson K. Differences in the incidence of hepatitis B and human immunodeficiency virus infection among injecting drug users. J. Infect. Dis. 173:1996;579-583
10. Marmor M., Des Jarlais D., Cohen H., Friedman S., Beatrice S., Dubin N., el-Sadr W., Mildvan D., Yancovitz S., Mathur U. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1:1987;39-44
11. Nelson K., Galai N., Safaeian M., Strathdee S., Celentano D., Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland 1988-1989. Am. J. Epidemiol. 156:2002a;641-653
12. Nelson K., Galai N., Safaeian M., Strathdee S., Celentano D., Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am. J. Epidemiol. 156:2002b;641-653
13. Nelson K., Vlahov D., Solomon L., Cohn S., Munoz A. Temporal trends of incident HIV infection in a cohort of injection drug users in Baltimore, Maryland. Arch. Int. Med. 155:1995;1305-1311
14. Nicolosi A., Leite M., Molinari S., Musicco M., Saracco A., Lazzarin A. Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and Northern Italy 1986-1990. J. Acquir. Immune Syndr. 5:1992a;365-372
15. Nicolosi A., Leite M., Musicco M., Molinari S., Lazzarin A. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am. J. Epidemiol. 135:1992b;225-233
16. Rothman, K., Greenland, S., 1998. Modern Epidemiology. Lippincott-Raven Publishers, Philadelphia, PA.
17. Samuels J., Vlahov D., Anthony J., Chaisson R. Measurement of HIV risk behaviors among intravenous drug users. Br. J. Addict. 87:1992;417-428
18. Schutz C., Vlahov D., Anthony J., Graham N. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J. Clin. Epidemiol. 47:1994;191-195
19. Strathdee S., Galai N., Safaiean M., Celentano D., Vlahov D., Johnson L., Nelson K. Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Arch. Int. Med. 161:2001;1281-1288
20. Thorpe L., Ouellet L., Levy J., Williams I., Monterroso E. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago 1997-1999. J. Infect. Dis. 182:2000;1588-1594
21. van Ameijden E., van den Hoek J., Mientjes G., Coutinho R. A longitudinal study on the incidence and transmission patterns of HIV, HBV, and HCV infection among injecting drug users in Amsterdam. Eur. J. Epidemiol. 9:1993;255-262
22. Vlahov D., Anthony J.C., Celentano D., Solomon L., Chowdhury N. Trends in HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am. J. Drug Alcohol Abuse. 17:1991;39-48
23. Vlahov D., Fuller C., Ompad D., Galea S., Des Jarlais D. Updating the infection risk reduction hierarchy: preventing transition into injection. J. Urban Health. 81:2004;14-19
24. Vlahov D., Munoz A., Anthony J., Cohn S., Celentano C., Nelson K. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am. J. Epidemiol. 132:1990;847-856
25. Zinberg, N., 1984. Drug, Set and Setting: the Basis for Controlled Intoxicant Use. Yale University Press, New Haven, CT.